160 related articles for article (PubMed ID: 36058999)
1. Fyn and Lyn gene polymorphisms impact the risk of thyroid cancer.
Nisar A; Kayani MA; Nasir W; Mehmood A; Ahmed MW; Parvez A; Mahjabeen I
Mol Genet Genomics; 2022 Nov; 297(6):1649-1659. PubMed ID: 36058999
[TBL] [Abstract][Full Text] [Related]
2. Linkage disequilibrium and haplotype analysis of
Nisar A; Mahjabeen I; Mehmood A; Ahmed MW; Khurshid K; Kayani MA
Future Oncol; 2020 Apr; 16(12):779-792. PubMed ID: 32253932
[No Abstract] [Full Text] [Related]
3. FYN kinase gene: another glutamatergic gene associated with bipolar disorder?
Szczepankiewicz A; Rybakowski JK; Skibinska M; Dmitrzak-Weglarz M; Leszczynska-Rodziewicz A; Wilkosc M; Hauser J
Neuropsychobiology; 2009; 59(3):178-83. PubMed ID: 19468241
[TBL] [Abstract][Full Text] [Related]
4. Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.
Zhang J; Zhao D; Zhang L; Xiao Y; Wu Q; Wang Y; Chen J; Zhan Q
Sci China Life Sci; 2023 Jun; 66(6):1245-1263. PubMed ID: 36763244
[TBL] [Abstract][Full Text] [Related]
5. The association of single nucleotide polymorphism of the Fyn gene with sporadic Alzheimer's disease in the Chinese Han population.
Li J; Zhou HD; Deng J; Zhu J; Li L; Zhang M; Zeng F; Wang YJ;
Neurosci Lett; 2014 Jul; 575():80-4. PubMed ID: 24852829
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
7. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
8. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
[TBL] [Abstract][Full Text] [Related]
9. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation.
Mkaddem SB; Murua A; Flament H; Titeca-Beauport D; Bounaix C; Danelli L; Launay P; Benhamou M; Blank U; Daugas E; Charles N; Monteiro RC
Nat Commun; 2017 Aug; 8(1):246. PubMed ID: 28811476
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation.
Luciano F; Ricci JE; Auberger P
Oncogene; 2001 Aug; 20(36):4935-41. PubMed ID: 11526478
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
12. Identification and activation of Src family kinases in primary megakaryocytes.
Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
[TBL] [Abstract][Full Text] [Related]
13. Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis.
Falanga YT; Chaimowitz NS; Charles N; Finkelman FD; Pullen NA; Barbour S; Dholaria K; Faber T; Kolawole M; Huang B; Odom S; Rivera J; Carlyon J; Conrad DH; Spiegel S; Oskeritzian CA; Ryan JJ
J Immunol; 2012 May; 188(9):4360-8. PubMed ID: 22450804
[TBL] [Abstract][Full Text] [Related]
14. Activation of src-related tyrosine kinases by IL-3.
Anderson SM; Jorgensen B
J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
[TBL] [Abstract][Full Text] [Related]
15. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn.
Yu CC; Yen TS; Lowell CA; DeFranco AL
Curr Biol; 2001 Jan; 11(1):34-8. PubMed ID: 11166177
[TBL] [Abstract][Full Text] [Related]
16. Distinctive roles of Fyn and Lyn in IgD- and IgM-mediated signaling.
Horikawa K; Nishizumi H; Umemori H; Aizawa S; Takatsu K; Yamamoto T
Int Immunol; 1999 Sep; 11(9):1441-9. PubMed ID: 10464165
[TBL] [Abstract][Full Text] [Related]
17. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
[TBL] [Abstract][Full Text] [Related]
18. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
[TBL] [Abstract][Full Text] [Related]
19. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.
Stettner MR; Wang W; Nabors LB; Bharara S; Flynn DC; Grammer JR; Gillespie GY; Gladson CL
Cancer Res; 2005 Jul; 65(13):5535-43. PubMed ID: 15994925
[TBL] [Abstract][Full Text] [Related]
20. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes.
Malek SN; Desiderio S
J Biol Chem; 1993 Oct; 268(30):22557-65. PubMed ID: 8226767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
